You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-BP180

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy Trial (characterisation of immunoglobulin

Not yet recruiting
  • Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy
  • characterisation of immunoglobulin subclasses
  • (no location specified)
Jan 9, 2023

Hypertension Trial in San Francisco (Anti-hypertensive agent: amlodipine, Anti-hypertensive agent: Chlorthalidone,

Recruiting
  • Hypertension
  • Anti-hypertensive agent: amlodipine
  • +5 more
  • San Francisco, California
    University of California San Francisco
May 6, 2022

Axial Spondyloarthritis Trial in Saint Petersburg (anti-TRBV9 mAb, low dose, anti-TRBV9 mAb, high dose, )

Recruiting
  • Axial Spondyloarthritis
  • anti-TRBV9 monoclonal antibody, low dose
  • +2 more
  • Saint Petersburg, Russian Federation
  • +1 more
Jun 30, 2022

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

End Stage Renal Disease on Dialysis Trial in San Francisco, Seattle (Dry weight target adjustment, Anti-hypertensive

Recruiting
  • End Stage Renal Disease on Dialysis
  • Dry weight target adjustment
  • Anti-hypertensive medications
  • San Francisco, California
  • +1 more
Jun 2, 2022

Hepatocellular Carcinoma Trial (ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w)

Not yet recruiting
  • Hepatocellular Carcinoma
  • ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w
  • (no location specified)
Jun 28, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Coronary Artery Bypass Graft, Radial Artery Grafts, Antispastic Therapy Trial in Shanghai (Nicorandil 5mg tid, Diltiazem 180mg

Active, not recruiting
  • Coronary Artery Bypass Graft
  • +3 more
  • Nicorandil 5mg tid
  • +2 more
  • Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Oct 17, 2022

Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Resectable Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +2 more
  • Houston, Texas
  • +1 more
Oct 12, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

Not yet recruiting
  • Bullous Pemphigoid
  • (no location specified)
Dec 27, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +6 more
  • Balstilimab
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Nov 17, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Bullous Pemphigoid Trial in Worldwide (dupilumab, Matching Placebo, Oral corticosteroids (OCS))

Recruiting
  • Bullous Pemphigoid
  • Scottsdale, Arizona
  • +50 more
Jan 13, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +8 more
  • Phoenix, Arizona
  • +25 more
Feb 2, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
Has Results
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer Trial in United States

Recruiting
  • Combined Hepatocellular Carcinoma and Cholangiocarcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Auburn, California
  • +16 more
Aug 17, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 14, 2021

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022